MoonLake Immunotherapeutics (MLTX) Q2 2026 Earnings

May 10Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.1
-0.98
-0.86
-0.74

Details

Expected EPS
-0.891771
Actual EPS
-0.98
Surprise EPS
-0.09
Surprise Percent
-9.89%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-0.98⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts